Publications by authors named "Anthony Coates"

Claim this Profile
C
Characterisation of Ferritin-Lymphocyte Ratio in COVID-19.
Alexander Liu, Robert Hammond, Kenneth Chan, Chukwugozie Chukwuenweniwe, Rebecca Johnson, Anthony R M Coates

Biomedicines· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low CRB-65 Scores Effectively Rule out Adverse Clinical Outcomes in COVID-19 Irrespective of Chest Radiographic Abnormalities.
Alexander Liu, Robert Hammond, Kenneth Chan, Chukwugozie Chukwuenweniwe, Rebecca Johnson, Anthony R M Coates

Biomedicines· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective prognostic and clinical risk stratification in COVID-19 using multimodality biomarkers.
Alexander Liu, Robert Hammond, Peter D Donnelly, Juan Carlos Kaski, Anthony R M Coates

J Intern Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Lymphocyte-CRP Ratio to Conventional Inflammatory Markers for Predicting Clinical Outcomes in COVID-19.
Alexander Liu, Robert Hammond, Kenneth Chan, Chukwugozie Chukwuenweniwe, Rebecca Johnson, Anthony R M Coates

J Pers Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Normal high-sensitivity cardiac troponin for ruling-out inpatient mortality in acute COVID-19.
Alexander Liu, Robert Hammond, Kenneth Chan, Chukwugozie Chukwuenweniwe, Rebecca Johnson, Anthony R M Coates

PLoS One· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Efficacy of Using Combination Therapy against Multi-Drug and Extensively Drug-Resistant in Clinical Settings.
Frank Jones, Yanmin Hu, Anthony Coates

Antibiotics (Basel)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zidovudine enhances activity of carbapenems against NDM-1-producing Enterobacteriaceae.
Yanmin Hu, Anthony Coates

J Antimicrob Chemother· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mefloquine enhances the activity of colistin against antibiotic-resistant Enterobacterales in vitro and in an in vivo animal study.
Yanmin Hu, Anthony Coates

Int J Antimicrob Agents· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A model-based analysis identifies differences in phenotypic resistance between in vitro and in vivo: implications for translational medicine within tuberculosis.
Oskar Clewe, Alan Faraj, Yanmin Hu, Anthony R M Coates, Ulrika S H Simonsson

J Pharmacokinet Pharmacodyn· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translational Model-Informed Approach for Selection of Tuberculosis Drug Combination Regimens in Early Clinical Development.
Budi O Susanto, Sebastian G Wicha, Yanmin Hu, Anthony R M Coates, Ulrika S H Simonsson

Clin Pharmacol Ther· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of allergic inflammation in the lung by a peptide derived from Mycobacteria tuberculosis chaperonin 60.1.
Yanira Riffo-Vasquez, Varsha Kanabar, Sandra D Keir, Rodrigo R E-Lacerda, Francis Man, Anthony R M Coates

Clin Exp Allergy· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibiotic combination therapy against resistant bacterial infections: synergy, rejuvenation and resistance reduction.
Anthony R M Coates, Yanmin Hu, James Holt, Pamela Yeh

Expert Rev Anti Infect Ther· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Different Media on the Bactericidal Activity of Colistin and on the Synergistic Combination With Azidothymidine Against Positive Colistin-Resistant .
Maria Loose, Kurt G Naber, Anthony Coates, Florian M E Wagenlehner, Yanmin Hu

Front Microbiol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary bactericidal activity of colistin and azidothymidine combinations against mcr-1-positive colistin-resistant Escherichia coli.
Maria Loose, Kurt G Naber, Yanmin Hu, Anthony Coates, Florian M E Wagenlehner

Int J Antimicrob Agents· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bedaquiline kills persistent Mycobacterium tuberculosis with no disease relapse: an in vivo model of a potential cure.
Yanmin Hu, Henry Pertinez, Yingjun Liu, Geraint Davies, Anthony Coates

J Antimicrob Chemother· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic activity of colistin with azidothymidine against colistin-resistant Klebsiella pneumoniae clinical isolates collected from inpatients in Greek hospitals.
Matthew E Falagas, Georgios L Voulgaris, Kyriaki Tryfinopoulou, Panagiota Giakkoupi, Margarita Kyriakidou, Anthony Coates

Int J Antimicrob Agents· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azidothymidine Produces Synergistic Activity in Combination with Colistin against Antibiotic-Resistant .
Yanmin Hu, Yingjun Liu, Anthony Coates

Antimicrob Agents Chemother· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Method to Evaluate Persistent Mycobacterium tuberculosis In Vitro and in the Cornell Mouse Model of Tuberculosis.
Yanmin Hu, Anthony Coates

Methods Mol Biol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Forecasting Clinical Dose-Response From Preclinical Studies in Tuberculosis Research: Translational Predictions With Rifampicin.
Sebastian G Wicha, Oskar Clewe, Robin J Svensson, Stephen H Gillespie, Yanmin Hu, Anthony R M Coates

Clin Pharmacol Ther· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum bactericidal activity of colistin and azidothymidine combinations against mcr-1-positive colistin-resistant Escherichia coli.
Maria Loose, Kurt G Naber, Yanmin Hu, Anthony Coates, Florian M E Wagenlehner

Int J Antimicrob Agents· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moxifloxacin Replacement in Contemporary Tuberculosis Drug Regimens Is Ineffective against Persistent Mycobacterium tuberculosis in the Cornell Mouse Model.
Yingjun Liu, Henry Pertinez, Geraint R Davies, Stephen H Gillespie, Anthony R Coates

Antimicrob Agents Chemother· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal doses of rifampicin in the standard drug regimen to shorten tuberculosis treatment duration and reduce relapse by eradicating persistent bacteria.
Yingjun Liu, Henry Pertinez, Fatima Ortega-Muro, Laura Alameda-Martin, Thomas Harrison, Anthony Coates

J Antimicrob Chemother· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing the action of HT61 and chlorhexidine on natural and model Staphylococcus aureus membranes.
Alasdair Tm Hubbard, Anthony Rm Coates, Richard D Harvey

J Antibiot (Tokyo)· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism of Action of a Membrane-Active Quinoline-Based Antimicrobial on Natural and Model Bacterial Membranes.
Alasdair T M Hubbard, Robert Barker, Reg Rehal, Kalliopi-Kelli A Vandera, Richard D Harvey, Anthony R M Coates

Biochemistry· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel erm(44) Gene Variant from a Human Staphylococcus saprophyticus Isolate Confers Resistance to Macrolides and Lincosamides but Not Streptogramins.
Christian Strauss, Yanmin Hu, Anthony Coates, Vincent Perreten

Antimicrob Agents Chemother· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis